Biagio Ricciuti, MD

Biagio Ricciuti, MD, is a medical thoracic oncologist at the Dana-Farber Cancer Institute.

Articles by Biagio Ricciuti, MD

Biagio Ricciuti, MD, explains why newer cancer therapies often require academic-center support before they can be safely and widely implemented in community settings.

Access Barriers Limit Community Adoption of Novel Therapies: Biagio Ricciuti, MD

February 12th 2026

Biagio Ricciuti, MD, discusses how access challenges and toxicity concerns slow the rollout of new T-cell engager therapies from academic centers into community oncology.

Biagio Ricciuti, MD

Articles by Biagio Ricciuti, MD

Access Barriers Limit Community Adoption of Novel Therapies: Biagio Ricciuti, MD

Latest Updated Articles

Trending on AJMC

Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets

FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer

Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care

Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc

Do Targeted NGS Panels Include NSCLC Guideline-Recommended Biomarkers?